Epitech Group SpA Report issue

For profit Phase 4
Founded: Saccolongo Italy (2001)

Organization Overview

First Clinical Trial
2020
NCT04488926
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Epitech Group SpA